Skip to content

folic acid/Finding

One finding, on its own

A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.

  • folic acid — no detected effect on all-site cancer incidence

    Evidence strength: moderate.FindingNull result
    “Allocation to folic acid treatment did not have any statistically significant effect on overall cancer incidence, with 1904 (7.7%) first events in 24,799 participants allocated folic acid versus 1809 (7.3%) in 24,822 allocated control (RR 1.06; 95% CI 0.99–1.13, p=0.10: Figure 1).”
    Quoted verbatim from Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals..
    Study
    meta-analysis
    Dose
    0.5 to 5 mg folic acid daily in all trials but one (40 mg daily); one trial compared 2.5 mg with 0.02 mg
    Population
    Adults in 13 randomised trials of folic acid versus placebo (10 trials in people with or at high risk of cardiovascular disease, 3 in patients with prior colorectal adenoma); mean age 64 years

    Effect 1.06 risk ratio, 95% CI 0.99 to 1.13

    Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals.2013PMID:2335255210.1016/S0140-6736(12)62001-7An author is affiliated with a producerPermalink

To cite this finding: https://catalystproject.ai/e/01M5JVX97F0FBNR659VZVS8JHC

Keep reading